Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions
Open Access
- 3 April 2017
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 106 (9), 2751-2757
- https://doi.org/10.1016/j.xphs.2017.03.027
Abstract
No abstract availableFunding Information
- National Institutes of Health (GM61390)
This publication has 32 references indexed in Scilit:
- Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound HeterozygoteThe Journal of pharmacology and experimental therapeutics, 2015
- Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?European Journal of Clinical Pharmacology, 2015
- Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human IntestineMolecular Pharmaceutics, 2014
- Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Published by H1 Connect ,2013
- Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG-CoA Reductase Inhibitors: A Kinetic Consideration of Its MechanismClinical Pharmacology & Therapeutics, 2012
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and RosuvastatinClinical Pharmacology & Therapeutics, 2009
- Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participantsPharmacogenetics and Genomics, 2007
- SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy VolunteersClinical Pharmacology & Therapeutics, 2007
- Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy VolunteersClinical Pharmacology & Therapeutics, 2006
- Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cellsPharmacogenetics and Genomics, 2005